glp-1 drugs pharmaceutical companies news 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Pharma Giants Bet on Next-Generation

Yang H, Kim HJ, Pyun BJ, Lee HW

Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming

Warning: For a drug intended for parenteral use, a visual inspection should be made before use in order to, if possible, determine the presence of particles or deviations in the color of the drug

Effects of zearalenone exposure on the TGF-1/Smad3 signaling pathway and the expression of proliferation or apoptosis related genes of post-weaning gilts

They mimic the action of naturally occurring GLP-1, a hormone released by the intestine in response to food intake

CJC 1295 and BPC 157 : These peptides have boosted muscle and improved healing in animal studies, but the FDA recently banned them due to a lack of human research regarding their safety (11)